Cipher Pharmaceuticals Inc.
OTC: CPHRF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Craig J. Mull
- Employees
- 6
- Headquarters
- Mississauga, Canada
- IPO year
- 2006
- Market cap
- $290.2M
- Website
- https://www.cipherpharma.com
Loading CPHRF…
Loading profile data…Frequently asked questions about CPHRF
What does Cipher Pharmaceuticals Inc. (CPHRF) do?
Cipher Pharmaceuticals Inc. functions as a specialized pharmaceutical company based in Canada. The firm markets a diverse portfolio of therapies, including Epuris (CIP-ISOTRETINOIN), an isotretinoin formulation specifically developed for addressing severe acne; Ozenoxacin, prescribed for the management of impetigo in both adult and pediatric pop...
Where does CPHRF trade?
Cipher Pharmaceuticals Inc. (CPHRF) trades on the Other OTC.
What sector is CPHRF in?
Cipher Pharmaceuticals Inc. (CPHRF) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Cipher Pharmaceuticals Inc.?
Craig J. Mull is the chief executive officer of Cipher Pharmaceuticals Inc. (CPHRF).
Where is Cipher Pharmaceuticals Inc. headquartered?
Cipher Pharmaceuticals Inc. is headquartered in Canada.
Does CPHRF pay a dividend?
Cipher Pharmaceuticals Inc. (CPHRF) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did CPHRF go public?
Cipher Pharmaceuticals Inc. (CPHRF) completed its initial public offering in 2006.